BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6259722)

  • 1. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
    Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Fosså SD; Miller A
    J Urol; 1976 Apr; 115(4):406-8. PubMed ID: 1263316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J
    Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
    [No Abstract]   [Full Text] [Related]  

  • 4. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
    Hedlund PO; Gustafson H; Sjögren S
    Scand J Urol Nephrol Suppl; 1980; 55():103-5. PubMed ID: 6938012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
    Benson RC
    Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
    Slack NH; Wajsman Z; Mittelman A; Bruno S; Murphy GP
    Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer of the prostate. Treating metastasis with estramustine phosphate.
    Hoeft RT; Jones AG
    Am J Nurs; 1982 May; 82(5):829-30. PubMed ID: 6918193
    [No Abstract]   [Full Text] [Related]  

  • 10. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
    Smith PH; Robinson M; Richards B; Suciu S; De Pauw M; Sylvester R; Denis L
    Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
    [No Abstract]   [Full Text] [Related]  

  • 12. Estramustine phosphate in the treatment of advanced prostatic cancer.
    Küss R; Khoury S; Richard F; Fourcade F; Frantz P; Capelle JP
    Br J Urol; 1980 Feb; 52(1):29-33. PubMed ID: 7426949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L; Edsmyr F; Jönsson G; Könyves I
    Recent Results Cancer Res; 1977; (60):73-7. PubMed ID: 866798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD; O'Donoghue EP; Kennedy CL
    Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU
    Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. The South Sweden Prostate Cancer Study Group.
    Lundgren R; Nordle O; Josefsson K
    J Urol; 1995 May; 153(5):1580-6. PubMed ID: 7714978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
    Fosså SD; Fosså J; Aakvaag A
    J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A; Lunglmayr G
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.